BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 1977164)

  • 1. Loss of heterozygosity on chromosomes 17 and 18 in breast carcinoma: two additional regions identified.
    Cropp CS; Lidereau R; Campbell G; Champene MH; Callahan R
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7737-41. PubMed ID: 1977164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of chromosome 17p loci in breast cancer cells detected by fluorescence in situ hybridization.
    Matsumura K; Kallioniemi A; Kallioniemi O; Chen L; Smith HS; Pinkel D; Gray J; Waldman FM
    Cancer Res; 1992 Jun; 52(12):3474-7. PubMed ID: 1350754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q.
    Devilee P; van Vliet M; van Sloun P; Kuipers Dijkshoorn N; Hermans J; Pearson PL; Cornelisse CJ
    Oncogene; 1991 Sep; 6(9):1705-11. PubMed ID: 1681492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of genetic alterations related to the development and progression of breast carcinoma.
    Nagayama K; Watatani M
    Jpn J Cancer Res; 1993 Nov; 84(11):1159-64. PubMed ID: 7903963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allelotype of neuroblastoma.
    Takita J; Hayashi Y; Kohno T; Shiseki M; Yamaguchi N; Hanada R; Yamamoto K; Yokota J
    Oncogene; 1995 Nov; 11(9):1829-34. PubMed ID: 7478611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas.
    Andersen TI; Gaustad A; Ottestad L; Farrants GW; Nesland JM; Tveit KM; Børresen AL
    Genes Chromosomes Cancer; 1992 Mar; 4(2):113-21. PubMed ID: 1373310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity on chromosome 17p13 in breast carcinomas identifies tumors with high proliferation index.
    Merlo GR; Venesio T; Bernardi A; Canale L; Gaglia P; Lauro D; Cappa AP; Callahan R; Liscia DS
    Am J Pathol; 1992 Jan; 140(1):215-23. PubMed ID: 1731526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. At least four different chromosomal regions are involved in loss of heterozygosity in human breast carcinoma.
    Devilee P; van den Broek M; Kuipers-Dijkshoorn N; Kolluri R; Khan PM; Pearson PL; Cornelisse CJ
    Genomics; 1989 Oct; 5(3):554-60. PubMed ID: 2575586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis.
    Niederacher D; Picard F; van Roeyen C; An HX; Bender HG; Beckmann MW
    Genes Chromosomes Cancer; 1997 Mar; 18(3):181-92. PubMed ID: 9071571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes.
    Moley JF; Brother MB; Fong CT; White PS; Baylin SB; Nelkin B; Wells SA; Brodeur GM
    Cancer Res; 1992 Feb; 52(4):770-4. PubMed ID: 1346584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of genetic alterations and progression of primary breast cancer.
    Sato T; Akiyama F; Sakamoto G; Kasumi F; Nakamura Y
    Cancer Res; 1991 Nov; 51(21):5794-9. PubMed ID: 1682035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion mapping of chromosomal region 1p32-pter in primary breast cancer.
    Bièche I; Khodja A; Lidereau R
    Genes Chromosomes Cancer; 1999 Mar; 24(3):255-63. PubMed ID: 10451706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q.
    Radford DM; Fair KL; Phillips NJ; Ritter JH; Steinbrueck T; Holt MS; Donis-Keller H
    Cancer Res; 1995 Aug; 55(15):3399-405. PubMed ID: 7614479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion mapping of chromosome 11 in carcinoma of the bladder.
    Shaw ME; Knowles MA
    Genes Chromosomes Cancer; 1995 May; 13(1):1-8. PubMed ID: 7541638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic mutations and human breast cancer. A status report.
    Callahan R; Cropp CS; Merlo GR; Liscia DS; Cappa AP; Lidereau R
    Cancer; 1992 Mar; 69(6 Suppl):1582-8. PubMed ID: 1540899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma.
    Ittmann MM
    Prostate; 1996 May; 28(5):275-81. PubMed ID: 8610052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic loss in ovarian cancer.
    Yang-Feng TL; Han H; Chen KC; Li SB; Claus EB; Carcangiu ML; Chambers SK; Chambers JT; Schwartz PE
    Int J Cancer; 1993 Jun; 54(4):546-51. PubMed ID: 8099899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of three regions on chromosome 17q in primary human breast carcinomas which are frequently deleted.
    Cropp CS; Champeme MH; Lidereau R; Callahan R
    Cancer Res; 1993 Dec; 53(23):5617-9. PubMed ID: 8242614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent deletions involving chromosomes 1, 5, 17, and 18 in colorectal carcinoma: possible role in biological and clinical behavior of tumors.
    Gerdes H; Chen Q; Elahi AH; Sircar A; Goldberg E; Winawer D; Urmacher C; Winawer SJ; Jhanwar SC
    Anticancer Res; 1995; 15(1):13-24. PubMed ID: 7733622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity of the L-myc oncogene in human breast tumors.
    Bieche I; Champeme MH; Merlo G; Larsen CJ; Callahan R; Lidereau R
    Hum Genet; 1990 Jun; 85(1):101-5. PubMed ID: 1972691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.